Following my comments, Bill will cover our financial performance and guidance. I'll highlight our full year financial performance and some key innovation, clinical and commercial wins. I'll start today's call by covering key patient metrics. And he is a significant addition to our team. He and I have known each other and worked together for many years. Bill previously served as CFO of Haemonetics and brings over 25 years of global financial and operational experience to ViewRay. Before we begin, I'd like to welcome our new Chief Financial Officer, Bill Burke. Good afternoon, everyone, and thank you for joining us to review our 2022 fourth quarter and full year results. Reconciliations to the most directly comparable GAAP financial measure and two years of historical results can be found in our appendix and exhibit of our current report on Form 8-K filed today with the SEC.

Factors that could cause actual results to differ materially are discussed in the company's most recent filings with the SEC.Īlso, the discussion will include non-GAAP financial measures. A replay will be available on our website for 14 days.īefore we begin, I would like to remind you that the discussion during this conference call will include forward-looking statements. Today's call is being broadcast and webcast live. Going forward, we will be providing an appendix of key metrics, which will be filed with our 8-K in lieu of an earnings presentation. Joining me today are Scott Drake, our President and Chief Executive Officer and Bill Burke, our Chief Financial Officer.Įarlier today, ViewRay issued a press release and appendix for today's call, both of which are available on our website. And welcome to ViewRay's fourth quarter conference call. I would now like to turn the conference over to Matt Harrison, Director of Investor Relations. This call is being recorded on Monday, February 27, 2023. Following the presentation, we will conduct the question-and-answer session. At this time, all lines are in a listen-only mode. And welcome to the ViewRay Q4 2022 Earnings Call. ( NASDAQ: VRAY) Q4 2022 Earnings Conference Call Febru4:30 PM ET

Vray 2022